Alpha Tau Medical
DRTS
14.25
-0.23
-1.59%
Alpha Tau Medical
US · DRTS
#3046 by market cap
Listed 1970
14.25
-0.23
-1.59%
Live - 5344 symbols - heartbeat 466s ago
· 2026-10-08 08:06
Pre-market
14.25
0.00%
After-hours
14.25
0.00%
- Market cap
- 1.32B
- P/E (TTM)i
- -13.70
- P/Bi
- 29.87
- EPSi
- -0.53
- Div yieldi
- 0.00%
- 52W posi
- 88%
Reader sentiment
Are you bullish or bearish on DRTS?
Anonymous reader poll. Unscientific, not investment advice.
About Alpha Tau Medical
Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.
- Founded
- 2015
- CEO
- Mr. Uzi Sofer
- Employees
- 121
- Headquarters
- Jerusalem, Jerusalem, Israel
- Fiscal year end
- 12-31
- Website
- alphatau.com
Company profile
- Exchange
- US
- Symbol
- DRTS
- Market-cap rank
- #3046
- Listing date
- 1970-01-01
- Market cap
- 1.32B
- Float cap
- 817.28M
- Shares out
- 92.33M
- Float shares
- 57.35M
Sectors & themes
Biotechnology
Quote time 2026-10-08 08:06:53 · For reference only, not investment advice and not tailored to your situation.